Clinical Trial Detail

NCT ID NCT02391480
Title A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie
Indications

breast cancer

Advanced Solid Tumor

lung non-small cell carcinoma

multiple myeloma

acute myeloid leukemia

Therapies

Mivebresib

Age Groups: adult

No variant requirements are available.